Evidence map›Paper›PMID 39086637›Full record

ArticleWorld journal of gastroenterology2024

Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients.

Li-Yang Meng, Chao-Ting Yang, Jian-Feng Bao, Jin-Song Huang

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Current status of drug therapy for chronic hepatitis B.World journal of gastroenterology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Li-Yang MengThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.
Chao-Ting YangThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.
Jian-Feng BaoDepartment of Hepatology, Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou 310023, Zhejiang Province, China.
Jin-Song HuangDepartment of Hepatology, Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou 310023, Zhejiang Province, China. huangjinsongyz@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This letter to the editor relates to the study entitled "Tenofovir amibufenamide

Indexed as

Antiviral AgentsHepatitis B, ChronicHepatitis B virusTenofovirAdenineAlanineHumansTreatment OutcomeVirus ReplicationAdenineAlanineAntiviral AgentsTenofovirtenofovir alafenamideAlanine transaminase normalizationChronic hepatitis BNon-alcoholic fatty liver diseaseTenofovir amibufenamideVirological response

Identifiers

PMID39086637
PMCPMC11287400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.